Literature DB >> 15918215

Attention and information processing in survivors of childhood acute lymphoblastic leukemia treated with chemotherapy only.

Maarten Mennes1, Peter Stiers, Erik Vandenbussche, Gertrui Vercruysse, Anne Uyttebroeck, Geert De Meyer, Stefaan W Van Cool.   

Abstract

BACKGROUND: Omitting radiotherapy for central nervous system (CNS) prophylaxis has improved the overall quality of life for long-term survivors of childhood acute lymphoblastic leukemia (ALL). However, recent reports suggest minor cognitive impairment in survivors who received chemotherapy only. PROCEDURE: This study focused on attentional functioning and speed of information processing in 23 children previously treated for ALL according to EORTC 58881 and EORTC 58951 protocol. Patients received intrathecal methotrexate combined with high doses intravenous methotrexate as CNS prophylaxis. Cognitive functioning was assessed with the Amsterdam Neuropsychological Tasks, a computerized attention assessment program. Variables of both speed and accuracy of the patients were compared with those obtained from 23 age- and sex-matched control children.
RESULTS: Patients were equal to control children concerning baseline speed, sustained attention, response inhibition, and response organization. However, they were significantly slower than controls in three tasks: encoding, memory search letters, and focused attention 4-letters. Interactions with the difficulty of the task were found. There were no differences in number or type of errors between groups on all tasks.
CONCLUSIONS: ALL survivors treated with chemotherapy have specific information processing difficulties. They process information slower than control children, especially when more information has to be processed or when attention has to be focused precisely. In spite of being slower, patients are equally accurate compared to control children. 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15918215     DOI: 10.1002/pbc.20147

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  21 in total

1.  Neurodevelopmental functioning in very young children undergoing treatment for non-CNS cancers.

Authors:  Marc H Bornstein; Sara Scrimin; Diane L Putnick; Fabia Capello; O Maurice Haynes; Simona de Falco; Modesto Carli; Marta Pillon
Journal:  J Pediatr Psychol       Date:  2012-02-02

2.  Declines Noted in Cognitive Processes and Association With Achievement Among Children With Leukemia.

Authors:  Kathleen C Insel; Marilyn J Hockenberry; Lynette L Harris; Kari M Koerner; Zhenqiang Lu; Kristin B Adkins; Olga A Taylor; Patricia M Gundy; Ida M Moore
Journal:  Oncol Nurs Forum       Date:  2017-07-01       Impact factor: 2.172

3.  Smaller white-matter volumes are associated with larger deficits in attention and learning among long-term survivors of acute lymphoblastic leukemia.

Authors:  Wilburn E Reddick; Zuyao Y Shan; John O Glass; Susan Helton; Xiaoping Xiong; Shengjie Wu; Melanie J Bonner; Scott C Howard; Robbin Christensen; Raja B Khan; Ching-Hon Pui; Raymond K Mulhern
Journal:  Cancer       Date:  2006-02-15       Impact factor: 6.860

4.  F2-isoprostanes: a measure of oxidative stress in children receiving treatment for leukemia.

Authors:  Marilyn J Hockenberry; Olga A Taylor; Patricia M Gundy; Adam K Ross; Alice Pasvogel; David Montgomery; Phillip Ribbeck; Kathy McCarthy; Ida Moore
Journal:  Biol Res Nurs       Date:  2013-08-15       Impact factor: 2.522

Review 5.  Executive dysfunction in pediatric posterior fossa tumor survivors: a systematic literature review of neurocognitive deficits and interventions.

Authors:  Kelly R Wolfe; Avi Madan-Swain; Rajesh K Kana
Journal:  Dev Neuropsychol       Date:  2012       Impact factor: 2.253

6.  Comparison of neurocognitive functioning in children previously randomly assigned to intrathecal methotrexate compared with triple intrathecal therapy for the treatment of childhood acute lymphoblastic leukemia.

Authors:  Nina S Kadan-Lottick; Pim Brouwers; David Breiger; Thomas Kaleita; James Dziura; Veronika Northrup; Lu Chen; Megan Nicoletti; Bruce Bostrom; Linda Stork; Joseph P Neglia
Journal:  J Clin Oncol       Date:  2009-11-02       Impact factor: 44.544

Review 7.  Puppets, robots, critics, and actors within a taxonomy of attention for developmental disorders.

Authors:  Maureen Dennis; Katia J Sinopoli; Jack M Fletcher; Russell Schachar
Journal:  J Int Neuropsychol Soc       Date:  2008-09       Impact factor: 2.892

8.  Voxel-based morphometry and diffusion-tensor MR imaging of the brain in long-term survivors of childhood leukemia.

Authors:  L Porto; C Preibisch; E Hattingen; M Bartels; T Lehrnbecher; R Dewitz; F Zanella; C Good; H Lanfermann; R DuMesnil; M Kieslich
Journal:  Eur Radiol       Date:  2008-05-20       Impact factor: 5.315

Review 9.  Quantitative morphologic evaluation of magnetic resonance imaging during and after treatment of childhood leukemia.

Authors:  Wilburn E Reddick; Fred H Laningham; John O Glass; Ching-Hon Pui
Journal:  Neuroradiology       Date:  2007-07-26       Impact factor: 2.804

10.  Neurocognitive and neuroradiologic central nervous system late effects in children treated on Pediatric Oncology Group (POG) P9605 (standard risk) and P9201 (lesser risk) acute lymphoblastic leukemia protocols (ACCL0131): a methotrexate consequence? A report from the Children's Oncology Group.

Authors:  Patricia K Duffner; Floyd Daniel Armstrong; Lu Chen; Kathleen J Helton; Martin L Brecher; Beverly Bell; Allen R Chauvenet
Journal:  J Pediatr Hematol Oncol       Date:  2014-01       Impact factor: 1.289

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.